Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2022 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.84B | 84.04B | 64.20B | 44.25B | 57.74B | 26.54B |
Gross Profit | 16.74B | 25.95B | 17.92B | 11.63B | 14.22B | 9.49B |
EBITDA | 8.35B | 13.37B | 10.74B | 6.82B | 7.72B | 5.36B |
Net Income | 3.16B | 4.35B | 4.91B | 4.26B | 4.42B | 3.14B |
Balance Sheet | ||||||
Total Assets | 117.22B | 117.22B | 112.95B | 47.85B | 54.33B | 37.26B |
Cash, Cash Equivalents and Short-Term Investments | 3.89B | 3.89B | 4.16B | 4.84B | 1.09B | 2.59B |
Total Debt | 55.71B | 55.71B | 49.83B | 7.86B | 10.29B | 7.24B |
Total Liabilities | 80.13B | 80.13B | 80.45B | 21.62B | 25.94B | 17.83B |
Stockholders Equity | 36.97B | 36.97B | 32.47B | 26.14B | 28.30B | 19.35B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -133.30M | 5.70B | -157.80M | -3.92B | 2.70B |
Operating Cash Flow | 0.00 | 7.60B | 11.05B | 2.90B | 5.04B | 3.85B |
Investing Cash Flow | 0.00 | -6.90B | -42.14B | -5.41B | -5.52B | -2.03B |
Financing Cash Flow | 0.00 | -639.30M | 33.81B | 2.17B | -305.70M | -1.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ₹107.22B | 57.88 | 0.48% | 10.29% | 26.09% | ||
68 Neutral | ₹85.79B | 13.51 | 1.87% | 3.26% | 19.18% | ||
66 Neutral | ₹169.27B | 21.44 | 0.44% | 39.44% | 256.03% | ||
65 Neutral | ₹142.13B | 34.61 | 1.46% | 16.06% | -17.84% | ||
63 Neutral | ₹70.30B | 41.12 | 0.70% | 7.10% | 29.32% | ||
62 Neutral | $10.28B | 6.21 | 0.76% | 2.84% | 3.10% | -36.03% | |
61 Neutral | ₹138.22B | 58.32 | 0.26% | 4.09% | -51.04% |
PCBL Chemical Limited has received an ESG rating of 66 from NSE Sustainability Ratings & Analytics Limited for the fiscal year 2023-24, reflecting its performance in environmental, social, and governance areas. This independent assessment highlights the company’s commitment to sustainability, potentially enhancing its reputation and stakeholder trust in the market.